Optima Medical Innovations Corp.
TOKIF
$0.00
$0.000.00%
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | 2.49% | -74.53% | 7.35% | -210.91% | -16.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.49% | -74.53% | 7.35% | -210.91% | -16.13% |
| Cost of Revenue | 12.50% | -74.91% | 36.22% | -173.24% | -5.51% |
| Gross Profit | -17.88% | -73.55% | -33.25% | -1,035.48% | -31.79% |
| SG&A Expenses | -33.14% | -95.13% | -44.54% | -190.19% | -75.61% |
| Depreciation & Amortization | -23.68% | -17.19% | -21.96% | -53.04% | -46.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.19% | -83.31% | -22.27% | -166.28% | -54.26% |
| Operating Income | 50.59% | 99.98% | 66.65% | 138.93% | 81.32% |
| Income Before Tax | 28.86% | 101.00% | 90.21% | 99.54% | 80.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 28.86% | 101.00% | 90.21% | 99.54% | 80.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.86% | 101.00% | 90.21% | 99.54% | 80.88% |
| EBIT | 50.59% | 99.98% | 66.65% | 138.93% | 81.32% |
| EBITDA | 71.00% | 106.67% | 76.98% | 150.38% | 87.03% |
| EPS Basic | 28.77% | 100.97% | 91.43% | 99.61% | 83.30% |
| Normalized Basic EPS | 36.00% | 101.03% | 90.83% | 118.47% | 81.68% |
| EPS Diluted | 28.77% | 100.97% | 91.43% | 99.61% | 83.30% |
| Normalized Diluted EPS | 36.00% | 101.03% | 90.83% | 118.47% | 81.68% |
| Average Basic Shares Outstanding | 0.83% | 4.40% | 12.02% | 14.04% | 14.42% |
| Average Diluted Shares Outstanding | 0.83% | 4.40% | 12.02% | 14.04% | 14.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
